Dynamics and Clinical Evolution of Bacterial Gut Microflora in Extremely Premature Patients - 20/08/11
Reprint requests: Jean-Charles Picaud, Service de néonatalogie, Hôpital de la Croix Rousse, 103 grande rue de la Croix Rousse, 69004 Lyon, France.Abstract |
Objective |
To determine baseline clinical characteristics that influence bacterial gut flora dynamics in very preterm infants and the relationship between gut flora dynamics and clinical evolution.
Study design |
Prospective, monocentric study enrolling 29 consecutive very preterm infants. We collected data about growth, digestive tolerance, nutrition, and antibiotic use. Microflora in stool samples, collected between 3 and 56 days of life, was identified with direct molecular fingerprinting.
Results |
Median (interquartile range) body weight and gestational age at birth were 950 g (760-1060 g) and 27 weeks (27-29 weeks), respectively. The diversity score (number of operational taxonomic units) increased 0.45 units/week (P < .0001), with staphylococci as the major group. Bifidobacterium was poorly represented. Gestational age (≥28 weeks) and caesarean delivery independently correlated with better diversity scores during follow-up (P < .05). The 6-week diversity score inversely correlated with the duration of antibiotherapy (P = .0184) and parenteral feeding (P = .013). The microflora dynamics was associated with the digestive tolerance profile. Weight gain increased with increasing diversity score (P = .0428).
Conclusion |
Microflora diversity settled progressively in very preterm infants. Staphylococci were the major group, and few infants were colonized with Bifidobacterium spp. Measures that may improve microflora could have beneficial effects on digestive tolerance and growth.
Le texte complet de cet article est disponible en PDF.Mots-clés : DDGE, DS, GA, HM, IQR, NEC, NICU, OTU, PCR, SSCP, TTGE
Plan
| The authors declare no conflicts of interest. |
Vol 158 - N° 3
P. 390-396 - mars 2011 Retour au numéro
Article précédent
- Randomized Controlled Trial of Lung Lavage with Dilute Surfactant for Meconium Aspiration Syndrome
- Peter A. Dargaville, Beverley Copnell, John F. Mills, Ismail Haron, Jimmy K.F. Lee, David G. Tingay, Jaafar Rohana, Lindsay F. Mildenhall, Mei-Jy Jeng, Anushree Narayanan, Malcolm R. Battin, Carl A. Kuschel, Joel L. Sadowsky, Harshad Patel, Charles J. Kilburn, John B. Carlin, Colin J. Morley, on behalf of the lessMAS Trial Study Group ∗
- Neonatal and Neurodevelopmental Outcomes of Very Low Birth Weight Infants with Histologic Chorioamnionitis
- Leonora Hendson, Laurie Russell, Charlene M.T. Robertson, Yuanyuan Liang, Yumin Chen, Abdelazim Abdalla, Thierry Lacaze-Masmonteil
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?